Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Farmers Insurance
Chinese Patent Office
Queensland Health
Fish and Richardson
Argus Health
US Army
QuintilesIMS
Deloitte
Cipla

Generated: December 12, 2017

DrugPatentWatch Database Preview

Cisplatin - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for cisplatin and what is the scope of cisplatin patent protection?

Cisplatin
is the generic ingredient in three branded drugs marketed by Accord Hlthcare, Bedford, Fresenius Kabi Usa, Gland Pharma Ltd, Hq Spclt Pharma, Mylan Labs Ltd, Pharmachemie Bv, Teva Pharms Usa, and West-ward Pharms Int, and is included in nine NDAs. Additional information is available in the individual branded drug profile pages.

There are fourteen drug master file entries for cisplatin. Eleven suppliers are listed for this compound.

Pharmacology for cisplatin

Medical Subject Heading (MeSH) Categories for cisplatin

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Patent Submitted Product Substance Delist Req. Exclusivity Expiration
Hq Spclt PharmaCISPLATINcisplatinINJECTABLE;INJECTION018057-004Nov 8, 1988APRXYesNo► Subscribe► Subscribe► Subscribe► Subscribe
BedfordCISPLATINcisplatinINJECTABLE;INJECTION074713-001Nov 14, 2000DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Teva Pharms UsaCISPLATINcisplatinINJECTABLE;INJECTION074814-001May 16, 2000DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
BedfordCISPLATINcisplatinINJECTABLE;INJECTION074713-002Nov 14, 2000DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Hq Spclt PharmaPLATINOL-AQcisplatinINJECTABLE;INJECTION018057-003Jul 18, 1984DISCNYesNo► Subscribe► Subscribe► Subscribe► Subscribe
Hq Spclt PharmaPLATINOLcisplatinINJECTABLE;INJECTION018057-002Approved Prior to Jan 1, 1982DISCNYesNo► Subscribe► Subscribe► Subscribe► Subscribe
Accord HlthcareCISPLATINcisplatinINJECTABLE;INJECTION206774-001Aug 18, 2015APRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Fresenius Kabi UsaCISPLATINcisplatinINJECTABLE;INJECTION074735-001Jul 16, 1999APRXNoYes► Subscribe► Subscribe► Subscribe► Subscribe
Pharmachemie BvCISPLATINcisplatinINJECTABLE;INJECTION074656-001May 16, 2000APRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Mylan Labs LtdCISPLATINcisplatinINJECTABLE;INJECTION091062-001Apr 18, 2012APRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Orange Book Patents for Generic Ingredient: cisplatin

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Hq Spclt PharmaPLATINOLcisplatinINJECTABLE;INJECTION018057-002Approved Prior to Jan 1, 1982► Subscribe► Subscribe
Hq Spclt PharmaCISPLATINcisplatinINJECTABLE;INJECTION018057-004Nov 8, 1988► Subscribe► Subscribe
Hq Spclt PharmaPLATINOL-AQcisplatinINJECTABLE;INJECTION018057-003Jul 18, 1984► Subscribe► Subscribe
Hq Spclt PharmaPLATINOL-AQcisplatinINJECTABLE;INJECTION018057-003Jul 18, 1984► Subscribe► Subscribe
Hq Spclt PharmaPLATINOLcisplatinINJECTABLE;INJECTION018057-002Approved Prior to Jan 1, 1982► Subscribe► Subscribe
Hq Spclt PharmaPLATINOLcisplatinINJECTABLE;INJECTION018057-001Approved Prior to Jan 1, 1982► Subscribe► Subscribe
Hq Spclt PharmaPLATINOL-AQcisplatinINJECTABLE;INJECTION018057-003Jul 18, 1984► Subscribe► Subscribe
Hq Spclt PharmaPLATINOLcisplatinINJECTABLE;INJECTION018057-001Approved Prior to Jan 1, 1982► Subscribe► Subscribe
Hq Spclt PharmaCISPLATINcisplatinINJECTABLE;INJECTION018057-004Nov 8, 1988► Subscribe► Subscribe
Hq Spclt PharmaCISPLATINcisplatinINJECTABLE;INJECTION018057-004Nov 8, 1988► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

US Army
Novartis
UBS
McKesson
Teva
Medtronic
Dow
Cantor Fitzgerald
Citi
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot